{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:30:53Z","timestamp":1773819053216,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12519-025-00902-w","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T11:06:01Z","timestamp":1745060761000},"page":"352-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gaps and challenges in the management of pediatric steatotic liver diseases: a narrative review"],"prefix":"10.1007","volume":"21","author":[{"given":"Wathsala","family":"Hathagoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaman","family":"Rajindrajith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7213-5858","authenticated-orcid":false,"given":"Madunil Anuk","family":"Niriella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"902_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2024;29:101133.","journal-title":"Ann Hepatol"},{"key":"902_CR2","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/jpn3.12156","volume":"78","author":"U Baumann","year":"2024","unstructured":"Baumann U, Koot BG, Fitzpatrick E, Mann J, Vajro P, Krag A, et al. Paediatric steatotic liver disease has unique characteristics: a multisociety statement endorsing the new nomenclature. J Pediatr Gastroenterol Nutr. 2024;78:1190\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"902_CR3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamapediatrics.2024.1576","volume":"178","author":"X Zhang","year":"2024","unstructured":"Zhang X, Liu J, Ni Y, Yi C, Fang Y, Ning Q, et al. Global prevalence of overweight and obesity in children and adolescents: a systematic review and meta-analysis. JAMA Pediatr. 2024;178:800\u201313.","journal-title":"JAMA Pediatr"},{"key":"902_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042843","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wu M, Liu Z, Yuan H, Wu X, Shi T, et al. Increasing prevalence of NAFLD\/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. BMJ Open. 2021;11:e042843.","journal-title":"BMJ Open"},{"key":"902_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.923744","volume":"10","author":"G Obita","year":"2022","unstructured":"Obita G, Alkhatib A. Disparities in the prevalence of childhood obesity-related comorbidities: a systematic review. Front Public Health. 2022;10:923744.","journal-title":"Front Public Health"},{"key":"902_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-013-2157-6","volume":"173","author":"S Berardis","year":"2014","unstructured":"Berardis S, Sokal E. Pediatric non-alcoholic fatty liver disease: an increasing public health issue. Eur J Pediatr. 2014;173:131\u20139.","journal-title":"Eur J Pediatr"},{"key":"902_CR7","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221\u201331.","journal-title":"N Engl J Med"},{"key":"902_CR8","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1210\/jc.2013-3612","volume":"99","author":"DA Lawlor","year":"2014","unstructured":"Lawlor DA, Callaway M, Macdonald-Wallis C, Anderson E, Fraser A, Howe LD, et al. Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. J Clin Endocrinol Metab. 2014;99:E410\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"902_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/jgh.12116","volume":"28","author":"J Alexander","year":"2013","unstructured":"Alexander J, Torbenson M, Wu TT, Yeh MM. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol. 2013;28:848\u201354.","journal-title":"J Gastroenterol Hepatol"},{"key":"902_CR10","doi-asserted-by":"crossref","unstructured":"Tovo CV, de Mattos AZ, Coral GP, Branco FS, Suwa E, de Mattos AA. Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy. World J Gastroenterol. 2015;21:4432\u20139","DOI":"10.3748\/wjg.v21.i15.4432"},{"key":"902_CR11","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1136\/gut.2008.171280","volume":"58","author":"AE Feldstein","year":"2009","unstructured":"Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009;58:1538\u201344.","journal-title":"Gut"},{"key":"902_CR12","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s00125-004-1460-1","volume":"47","author":"J Westerbacka","year":"2004","unstructured":"Westerbacka J, Corn\u00e9r A, Tiikkainen M, Tamminen M, Vehkavaara S, H\u00e4kkinen AM, et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004;47:1360\u20139.","journal-title":"Diabetologia"},{"key":"902_CR13","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1053\/j.gastro.2007.08.077","volume":"133","author":"A Fraser","year":"2007","unstructured":"Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999\u20132004. Gastroenterology. 2007;133:1814\u201320.","journal-title":"Gastroenterology"},{"key":"902_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/ajcn\/82.5.1046","volume":"82","author":"HS Park","year":"2005","unstructured":"Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005;82:1046\u201351.","journal-title":"Am J Clin Nutr"},{"key":"902_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2431-14-25","volume":"14","author":"PA Monteiro","year":"2014","unstructured":"Monteiro PA, Antunes BDEM, Silveira LS, Christofaro DG, Fernandes RA, Freitas Junior IF. Body composition variables as predictors of NAFLD by ultrasound in obese children and adolescents. BMC Pediatr. 2014;14:25.","journal-title":"BMC Pediatr"},{"key":"902_CR16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","volume":"54","author":"P Vajro","year":"2012","unstructured":"Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012;54:700\u201313.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"902_CR17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745\u201350.","journal-title":"Gastroenterology"},{"key":"902_CR18","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00247-014-3024-y","volume":"44","author":"J Deng","year":"2014","unstructured":"Deng J, Fishbein MH, Rigsby CK, Zhang G, Schoeneman SE, Donaldson JS. Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease. Pediatr Radiol. 2014;44:1379\u201387.","journal-title":"Pediatr Radiol"},{"key":"902_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.metabol.2015.04.002","volume":"64","author":"SE Regnell","year":"2015","unstructured":"Regnell SE, Peterson P, Trinh L, Broberg P, Leander P, Lernmark \u00c5, et al. Magnetic resonance imaging reveals altered distribution of hepatic fat in children with type 1 diabetes compared to controls. Metabolism. 2015;64:872\u20138.","journal-title":"Metabolism"},{"key":"902_CR20","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/hep.27666","volume":"61","author":"JB Schwimmer","year":"2015","unstructured":"Schwimmer JB, Middleton MS, Behling C, Newton KP, Awai HI, Paiz MN, et al. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology. 2015;61:1887\u201395.","journal-title":"Hepatology"},{"key":"902_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cgh.2010.09.015","volume":"9","author":"N Alkhouri","year":"2011","unstructured":"Alkhouri N, Carter-Kent C, Lopez R, Rosenberg WM, Pinzani M, Bedogni G, et al. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol. 2011;9:150\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"902_CR22","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/hep.26299","volume":"57","author":"MB Vos","year":"2013","unstructured":"Vos MB, Lavine JE. Dietary fructose in nonalcoholic fatty liver disease. Hepatology. 2013;57:2525\u201331.","journal-title":"Hepatology"},{"key":"902_CR23","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1161\/CIR.0000000000000439","volume":"135","author":"MB Vos","year":"2017","unstructured":"Vos MB, Kaar JL, Welsh JA, van Horn LV, Feig DI, Anderson CAM, et al. Added sugars and cardiovascular disease risk in children: a scientific statement from the American heart association. Circulation. 2017;135:e1017\u201334.","journal-title":"Circulation"},{"key":"902_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3945\/jn.109.112573","volume":"140","author":"HK Seligman","year":"2010","unstructured":"Seligman HK, Laraia BA, Kushel MB. Food insecurity is associated with chronic disease among low-income NHANES participants. J Nutr. 2010;140:304\u201310.","journal-title":"J Nutr"},{"key":"902_CR25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797\u2013835.","journal-title":"Hepatology"},{"key":"902_CR26","doi-asserted-by":"publisher","first-page":"E1088","DOI":"10.1210\/jc.2012-1370","volume":"97","author":"R Jin","year":"2012","unstructured":"Jin R, Le NA, Liu S, Farkas Epperson M, Ziegler TR, Welsh JA, et al. Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. J Clin Endocrinol Metab. 2012;97:E1088\u201398.","journal-title":"J Clin Endocrinol Metab"},{"key":"902_CR27","doi-asserted-by":"crossref","unstructured":"O\u02bcSullivan TA, Oddy WH, Bremner AP, Sherriff JL, Ayonrinde OT, Olynyk JK, et al. Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity. J Pediatr Gastroenterol Nutr. 2014;58:624\u201331.","DOI":"10.1097\/MPG.0000000000000267"},{"key":"902_CR28","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1023\/B:DDAS.0000043367.69470.b7","volume":"49","author":"S Solga","year":"2004","unstructured":"Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM, et al. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci. 2004;49:1578\u201383.","journal-title":"Dig Dis Sci"},{"key":"902_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jama.2018.20579","volume":"321","author":"JB Schwimmer","year":"2019","unstructured":"Schwimmer JB, Ugalde-Nicalo P, Welsh JA, Angeles JE, Cordero M, Harlow KE, et al. Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial. JAMA. 2019;321:256\u201365.","journal-title":"JAMA"},{"key":"902_CR30","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.2337\/dc13-0955","volume":"36","author":"D Corella","year":"2013","unstructured":"Corella D, Carrasco P, Sorl\u00ed JV, Estruch R, Rico-Sanz J, Mart\u00ednez-Gonz\u00e1lez M\u00c1, et al. Mediterranean diet reduces the adverse effect of the TCF7L2-rs7903146 polymorphism on cardiovascular risk factors and stroke incidence: a randomized controlled trial in a high-cardiovascular-risk population. Diabetes Care. 2013;36:3803\u201311.","journal-title":"Diabetes Care"},{"key":"902_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1741-7015-9-70","volume":"9","author":"V Nobili","year":"2011","unstructured":"Nobili V, Carter-Kent C, Feldstein AE. The role of lifestyle changes in the management of chronic liver disease. BMC Med. 2011;9:70.","journal-title":"BMC Med"},{"key":"902_CR32","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1186\/s12889-024-19227-w","volume":"24","author":"X Cheng","year":"2024","unstructured":"Cheng X, Guo Q, Ju L, Gong W, Wei X, Xu X, et al. Association between sedentary behavior, screen time and metabolic syndrome among Chinese children and adolescents. BMC Public Health. 2024;24:1715.","journal-title":"BMC Public Health"},{"key":"902_CR33","doi-asserted-by":"publisher","first-page":"E1555","DOI":"10.3390\/nu12061555","volume":"12","author":"AL Han","year":"2020","unstructured":"Han AL. Association between non-alcoholic fatty liver disease and dietary habits, stress, and health-related quality of life in Korean adults. Nutrients. 2020;12:E1555.","journal-title":"Nutrients"},{"key":"902_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41598-019-57036-z","volume":"10","author":"D Kang","year":"2020","unstructured":"Kang D, Zhao D, Ryu S, Guallar E, Cho J, Lazo M, et al. Perceived stress and non-alcoholic fatty liver disease in apparently healthy men and women. Sci Rep. 2020;10:38.","journal-title":"Sci Rep"},{"key":"902_CR35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/MPG.0000000000003024","volume":"72","author":"SL Noon","year":"2021","unstructured":"Noon SL, D\u2019Annibale DA, Schwimmer MH, Shiels J, Arin J, Durelle J, et al. Incidence of depression and anxiety in a cohort of adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2021;72:579\u201383.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"902_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5223\/pghn.2020.23.1.15","volume":"23","author":"NR Kang","year":"2020","unstructured":"Kang NR, Kwack YS. An update on mental health problems and cognitive behavioral therapy in pediatric obesity. Pediatr Gastroenterol Hepatol Nutr. 2020;23:15\u201325.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"902_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/chi.2011.07.02.1004.berge","volume":"7","author":"JM Berge","year":"2011","unstructured":"Berge JM, Everts JC. Family-based interventions targeting childhood obesity: a meta-analysis. Child Obes. 2011;7:110\u201321.","journal-title":"Child Obes"},{"key":"902_CR38","first-page":"407","volume":"14","author":"J Shah","year":"2018","unstructured":"Shah J, Okubote T, Alkhouri N. Overview of updated practice guidelines for pediatric nonalcoholic fatty liver disease. Gastroenterol Hepatol (N Y). 2018;14:407\u201314.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"902_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrgastro.2011.273","volume":"9","author":"A Alisi","year":"2012","unstructured":"Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol. 2012;9:152\u201361.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"902_CR40","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/EJE-13-0609","volume":"170","author":"V Nobili","year":"2014","unstructured":"Nobili V, Giorgio V, Liccardo D, Bedogni G, Morino G, Alisi A, et al. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol. 2014;170:547\u201353.","journal-title":"Eur J Endocrinol"},{"key":"902_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12072-008-9062-5","volume":"2","author":"S Rajindrajith","year":"2008","unstructured":"Rajindrajith S, Dassanayake AS, Hewavisenthi J, de Silva HJ. Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary report. Hepatol Int. 2008;2:209\u201312.","journal-title":"Hepatol Int"},{"key":"902_CR42","doi-asserted-by":"crossref","unstructured":"Nobili V, Svegliati-Baroni G, Alisi A, Miele, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol. 2013;58:1218\u201329","DOI":"10.1016\/j.jhep.2012.12.003"},{"key":"902_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/children11030275","volume":"11","author":"E Choi","year":"2024","unstructured":"Choi E, Ramirez Tovar A, He Z, Soler Rodriguez DM, Vos MB, Arora S, et al. Glucagon-like peptide-1 receptor agonists-a potential new medication for pediatric metabolic-dysfunction-associated steatotic liver disease (MASLD). Children. 2024;11:275.","journal-title":"Children"},{"key":"902_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jpn3.12402","volume":"80","author":"RAR Abou Jaoudeh","year":"2025","unstructured":"Abou Jaoudeh RAR, Hartmann P, Olson O, Gupta O, Kumar S, Ibrahim SH, et al. Pharmacological management of pediatric metabolic dysfunction-associated steatotic liver disease. J Pediatr Gastroenterol Nutr. 2025;80:14\u201324.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"902_CR45","doi-asserted-by":"publisher","DOI":"10.1097\/PG9.0000000000000126","volume":"2","author":"T Kohut","year":"2021","unstructured":"Kohut T, Serai S, Panganiban J. Utilization of topiramate as an adjunct to lifestyle intervention for weight loss in pediatric nonalcoholic fatty liver disease. JPGN Rep. 2021;2:e126.","journal-title":"JPGN Rep"},{"key":"902_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2020.08.008","volume":"45","author":"M Lin","year":"2021","unstructured":"Lin M, Zeng H, Deng G, Lei J, Li J. Vitamin E in paediatric non-alcoholic fatty liver disease: a meta-analysis. Clin Res Hepatol Gastroenterol. 2021;45:101530.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"902_CR47","first-page":"221","volume":"14","author":"DI Patoulias","year":"2019","unstructured":"Patoulias DI. Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived? Prz Gastroenterol. 2019;14:221\u20132.","journal-title":"Prz Gastroenterol"},{"key":"902_CR48","first-page":"252","volume":"30","author":"C Conroy","year":"2024","unstructured":"Conroy C, Radulescu A, Attia SL, Shelman N, Lee JT, Monticelli RG, et al. The combined pioglitazone and topiramate therapy for management of pediatric patients with severe MASLD. Saudi J Gastroenterol. 2024;30:252\u20139.","journal-title":"Saudi J Gastroenterol"},{"key":"902_CR49","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1542\/peds.2006-1212","volume":"118","author":"JB Schwimmer","year":"2006","unstructured":"Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388\u201393.","journal-title":"Pediatrics"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-025-00902-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-025-00902-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-025-00902-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T19:02:46Z","timestamp":1748113366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-025-00902-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["902"],"URL":"https:\/\/doi.org\/10.1007\/s12519-025-00902-w","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}